Remarkably, as observed for XPD, mutations in XPG also lead to XP or XP-CS phenotypes, suggesting that part of these phenotypes are related to a reduced capacity to anchor CAK to TFIIH resulting in increased free CAK activity. The gene discussed is ERCC2; the disease is Cowden syndrome 1.